ArticleTrials2024

Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial.

Li-Xin Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.